Learning Activity Title
Pressed by rising resistance and SEP-1 pressure? In this rapid update, synthesize high-yield moves: don’t treat asymptomatic bacteriuria; at discharge, stop when you can, choose narrower non–fluoroquinolone agents, and document dose, indication, and duration. Then apply tactics to counter diagnosis momentum and interruptions. You’ll treat faster and safer, meet Joint Commission/CMS expectations, and cut adverse events and length of stay.